Tipping point passe'?

Data from Medicare Australia would indicate that in Australia QFT has just recently overtaken TST as the test of choice. This is a significant market penetration as the TB medical authorities in Australia are demonstrably conservative and, unlike authorities in UK, EU, Japan and US, have expressed reluctance in endorsing IGRA.

Click on image for FULL SIZE